Novartis to Prepare the Sale of Its Roche Stake: Sonntagszeitung
Roche shareholders approve deal to buy Novartis's $20.7 billion stake | Reuters
Novartis exits 20-year Roche stake, creating a $20.7B question about CEO Vas Narasimhan's next M&A move | Fierce Pharma
Novartis India | Novartis AG to sell nearly one-third voting stake in Roche - Telegraph India
Novartis launches $15B share buyback after huge windfall from Roche stake sale—but M&A is still in the cards | Fierce Pharma
Novartis considers future of $14bn Roche stake
Novartis Unwinds Roche Ties With $20.7 Billion Stake Sale - BNN Bloomberg
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3L5H7O5F6RPD7LKCUDTF5LWOEU.jpg "Novartis cuts uneasy 20-year ties to Roche with $20.7 bln voting stake sale | Reuters")
Novartis cuts uneasy 20-year ties to Roche with $20.7 bln voting stake sale | Reuters
Novartis Unwinds Roche Ties With $20.7 Billion Stake Sale - Bloomberg
Novartis takes 20 per cent stake in rivals Roche - SWI swissinfo.ch
Novartis Has a Big Pile of Cash and Investors Are Demanding Action - BNN Bloomberg
Novartis to sell its stake in Roche to Roche for $20.7bn
Novartis AG to Hold On to Its 33% Stake in Roche—For Now | BioSpace
No sale for Novartis' $14B Roche stake, but the revamp's not done | Fierce Pharma
 "Novartis cuts uneasy 20-year ties to Roche with $20.7-bn voting stake sale | INTERNATIONAL COMPANIES NEWS - Business Standard")
Novartis cuts uneasy 20-year ties to Roche with $20.7-bn voting stake sale | INTERNATIONAL COMPANIES NEWS - Business Standard
Novartis willing to sell Roche stake without demanding premium - CEO | Reuters
Novartis puts $14B Roche stake up for sale: Reports | Fierce Pharma
Novartis is cashing out of Roche for $21B, 20 years after mega-merger that never happened - MedCity News
Novartis Sells Shares Back to Roche for $20.7 Billion | BioSpace
Novartis to buy back up to $15 billion of its shares | Mint
Novartis is selling its Roche stake to Roche for $20.7 bln - THE CEO PUBLICATION
Novartis to sell Roche shares back for $20.7 billion
Novartis/Roche: When a Separation Makes Sense for Everyone - WSJ
